Previous studies have demonstrated that the IL-6 gene expression is activated by tumor-producing TGFβ in many cell types, including human prostate cancer cells, fibroblasts, osteoblasts, and retinal pigmented epithelial cells [17,18,19,20,21,22,23,24]. Here, IL6 is linked to prostate carcinoma.